As a seasoned Competitive Intelligence Senior Manager at Lundbeck, Renée brings over a decade of expertise in the pharmaceutical industry. Renée's tenure at TPR-Group honed her skills in managing a diverse portfolio of projects, delivering data-driven insights to stakeholders, and mastering the intricacies of market access and regulatory processes. Renée's academic background, including a Ph.D. in peptide synthesis and a role as a teaching assistant, has provided a strong foundation in research and education. Renée's work is characterized by a keen analytical acumen and a commitment to supporting strategic decision-making through comprehensive competitive landscape analysis.

Lundbeck is a biopharmaceutical company focused exclusively on neuroscience. We discover, develop, and commercialize treatments that improve the lives of people affected by neurological and psychiatric diseases. As a focused innovator, we strive for our research and development programs to tackle some of the most complex challenges. We develop transformative medicines targeting people for whom there are few, if any, treatment options. We are 5,600 employees in more than 50 countries, and our products are available in more than 100 countries. We have research facilities in Denmark and the United States, and our production facilities are located in Denmark, France, and Italy. Whether we work in labs, at desks, or in the field, we work closely with patients, healthcare professionals, and the neuroscience community to uncover causes, find new treatments, and fight stigma and discrimination against people living with brain diseases.